Resveratrol in Knee Osteoarthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

November 9, 2017

Primary Completion Date

February 9, 2022

Study Completion Date

May 12, 2022

Conditions
Knee Osteoarthritis
Interventions
DRUG

oral resveratrol

Resveratrol will be administered orally, at the dose of 40 mg (2 caplets) twice a day for one week, then at the dose of 20 mg (1 caplet) twice a day, for a total duration of 6 months.

DRUG

oral placebo

Placebo will be administered orally : 2 caplets twice a day for one week, then 1 caplet twice a day, for a total duration of 6 months

Trial Locations (3)

63118

Rehabilitation department , CHU Clermont-Ferrand, Cébazat

75012

Rheumatology Department, Saint Antoine Hospital, Paris

75014

Rehabilitation Department, Cochin Hospital, Paris

All Listed Sponsors
collaborator

URC-CIC Paris Descartes Necker Cochin

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02905799 - Resveratrol in Knee Osteoarthritis | Biotech Hunter | Biotech Hunter